Author of the publication

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed. You can also use the button next to the name to display some publications already assigned to the person.

 

Other publications of authors with the same name

A highly immunogenic and protective MERS-Coronavirus vaccine based on recombinant MV vaccine platform, , , , , , , , , and 14 other author(s). J Virol, 89 (22): 11654-11667 (2015)ICOS-LICOS interaction is critically involved in TGN1412-mediated T cell activation, , , , , and . Blood, 119 (26): 6268-6277 (2012)Characterization of the interferon-producing cell in mice infected with Listeria monocytogenes, , , , , , , , , and 6 other author(s). PLoS Pathog, 5 (3): e1000355 (2009)Influenza B virus ribonucleoprotein is a potent activator of the antiviral kinase PKR, , , , , , , and . PLoS Pathog, 5 (6): e1000473 (2009)A fusion protein of flagellin and ovalbumin suppresses the T(H)2 response and prevents murine intestinal allergy., , , , , , , , and . J Allergy Clin Immunol, 128 (6): 1340-1348 e1312 (2011)CD40 ligand-triggered human dendritic cells mount interleukin-23 responses that are further enhanced by danger signals., , , , , and . Mol Immunol, 47 (6): 1255-1261 (2010)Vaccinia virus-mediated inhibition of type I interferon responses is a multifactorial process involving the soluble type I interferon receptor B18 and intracellular components, , , , , , , , , and . J Virol, 83 (4): 1563-1571 (2009)Activation of cannabinoid 2 receptors protects against cerebral ischemia by inhibiting neutrophil recruitment., , , , , , , , , and . FASEB J, 24 (3): 788-798 (2010)Signaling signatures and functional properties of anti-human CD28 superagonistic antibodies, , , , , , , , and . PLoS One, 3 (3): e1708 (2008)Excessive CpG 1668 stimulation triggers IL-10 production by cDC that inhibits IFN-alpha responses by pDC, , , , , and . Eur J Immunol, 38 (11): 3127-3137 (2008)